德国纵向处方数据库 (LRx):特征描述,在药物流行病学研究中的使用,以及限制
International journal of clinical pharmacology and therapeutics
|November 16, 2023
概括
德国纵向处方 (LRx) 数据库为药物流行病学研究提供了宝贵的患者级处方数据. 尽管存在诸如缺失诊断等局限性,但它
科学领域:
- 药学流行病学 药学流行病学
- 医疗保健服务研究 医疗服务研究
- 药物使用研究 药物利用研究
背景情况:
- 大型数据库对于药物流行病学研究至关重要.
- 德国纵向处方 (LRx) 数据库约占法定医疗保险处方的80%.
- 与一般保险人群相比,这个数据库中的老年人和女性比例过高.
研究的目的:
- 描述德国纵向处方 (LRx) 数据库的特征.
- 概述LRx数据库在药物流行病学研究中的最新应用.
- 为了确定LRx数据库研究的局限性.
主要方法:
- 来自德国零售药店的患者级处方数据的分析.
- 评估各种治疗类别的药物覆盖范围.
- 使用LRx数据库发表的药物流行病学研究的审查.
主要成果:
- LRx数据库提供了关于处方模式,治疗坚持和持续性的全面数据.
- 研究已经研究了许多疾病,包括2型糖尿病,炎症性疾病和精神疾病.
- 在LRx数据库中,药物类别的覆盖范围从71.8% (抗药) 到94.7% (泌尿器官药物).
结论:
- 德国LRx数据库是药物流行病学研究的重要资源.
- 未来的研究可以利用LRx数据了解处方行为和治疗结果.
- 关键的局限性包括缺乏正式诊断和入院数据.
相关概念视频
Analysis of Population Pharmacokinetic Data
266
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
266
Prescription, Nonprescription and Orphan Drugs
741
Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
741
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
67
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
67
Pharmacovigilance
857
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
857
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
73
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
73
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


